On August 23, 2024, Gregory Weinhoff, the Chief Business Officer of Centessa Pharmaceuticals PLC (NASDAQ:CNTA), performed a significant transaction by selling 30,000 shares of the company’s stock. The sale was documented in a recent SEC filing. Following this transaction, the insider now owns 223,369 shares of Centessa Pharmaceuticals PLC. Centessa Pharmaceuticals PLC, trading under the […]